These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
24. Performance enhancing drug abuse and cardiovascular risk in athletes: implications for the clinician. Angell PJ; Chester N; Sculthorpe N; Whyte G; George K; Somauroo J Br J Sports Med; 2012 Nov; 46 Suppl 1():i78-84. PubMed ID: 23097484 [TBL] [Abstract][Full Text] [Related]
25. The efficacy of ergogenic agents in athletic competition. Part II: Other performance-enhancing agents. Smith DA; Perry PJ Ann Pharmacother; 1992 May; 26(5):653-9. PubMed ID: 1591427 [TBL] [Abstract][Full Text] [Related]
26. Banned drugs in sport. Does the International Olympic Committee (IOC) list need updating? Mottram DR Sports Med; 1999 Jan; 27(1):1-10. PubMed ID: 10028129 [TBL] [Abstract][Full Text] [Related]
27. The Role of Genetics in Moderating the Inter-Individual Differences in the Ergogenicity of Caffeine. Southward K; Rutherfurd-Markwick K; Badenhorst C; Ali A Nutrients; 2018 Sep; 10(10):. PubMed ID: 30248915 [TBL] [Abstract][Full Text] [Related]
28. Caffeine and exercise: metabolism, endurance and performance. Graham TE Sports Med; 2001; 31(11):785-807. PubMed ID: 11583104 [TBL] [Abstract][Full Text] [Related]
29. Attention deficit/hyperactivity disorder and psychopharmacologic treatments in the athlete. Conant-Norville DO; Tofler IR Clin Sports Med; 2005 Oct; 24(4):829-43, viii. PubMed ID: 16169448 [TBL] [Abstract][Full Text] [Related]
30. Nutrition for improved sports performance. Current issues on ergogenic aids. Clarkson PM Sports Med; 1996 Jun; 21(6):393-401. PubMed ID: 8784959 [TBL] [Abstract][Full Text] [Related]
31. Stimulants and Athletic Performance (Part 1 of 2): Amphetamines and Caffeine. Lombardo JA Phys Sportsmed; 1986 Nov; 14(11):128-39. PubMed ID: 27456643 [TBL] [Abstract][Full Text] [Related]
32. Antidepressant use of amphetamines and other psychostimulants. Wittenborn JR Mod Probl Pharmacopsychiatry; 1982; 18():178-95. PubMed ID: 6124882 [No Abstract] [Full Text] [Related]
33. Drugs and exercise. Rosenbloom D; Sutton JR Med Clin North Am; 1985 Jan; 69(1):177-87. PubMed ID: 3883074 [TBL] [Abstract][Full Text] [Related]
34. Antidoping program: an important factor in the promotion and protection of the integrity of sport and athlete's health. Mazzeo F; Monda V; Santamaria S; Nigro E; Valenzano A; Villano I; Cibelli G; Messina A; Messina G J Sports Med Phys Fitness; 2018; 58(7-8):1135-1145. PubMed ID: 28738670 [TBL] [Abstract][Full Text] [Related]
35. Medication use in athletes selected for doping control at the Sydney Olympics (2000). Corrigan B; Kazlauskas R Clin J Sport Med; 2003 Jan; 13(1):33-40. PubMed ID: 12544162 [TBL] [Abstract][Full Text] [Related]
36. Self-reported attitudes of elite athletes towards doping: differences between type of sport. Alaranta A; Alaranta H; Holmila J; Palmu P; Pietilä K; Helenius I Int J Sports Med; 2006 Oct; 27(10):842-6. PubMed ID: 16586338 [TBL] [Abstract][Full Text] [Related]
37. Myocardial infarction in an adolescent taking Adderall. Gandhi PJ; Ezeala GU; Luyen TT; Tu TC; Tran MT Am J Health Syst Pharm; 2005 Jul; 62(14):1494-7. PubMed ID: 15998931 [No Abstract] [Full Text] [Related]
38. Athletes and Supplements: Prevalence and Perspectives. Garthe I; Maughan RJ Int J Sport Nutr Exerc Metab; 2018 Mar; 28(2):126-138. PubMed ID: 29580114 [TBL] [Abstract][Full Text] [Related]
39. The effects of caffeine on ventilation and pulmonary function during exercise: an often-overlooked response. Chapman RF; Mickleborough TD Phys Sportsmed; 2009 Dec; 37(4):97-103. PubMed ID: 20048546 [TBL] [Abstract][Full Text] [Related]
40. Drug use and abuse in sport. Verroken M Baillieres Best Pract Res Clin Endocrinol Metab; 2000 Mar; 14(1):1-23. PubMed ID: 10932807 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]